Skip to main content
Premium Trial:

Request an Annual Quote

Greg Lucier, Integrated DNA Technologies, Qiagen, Sigma-Aldrich

Premium

People in the News

Greg Lucier has become a member of the board of trustees of the Burnham Institute, the La Jolla, Calif.-based institute said last week.

He is currently president and chief executive officer of Invitrogen.

 

Products & Services

Integrated DNA Technologies said this week that it has launched the Trifecta Dicer-substrate RNAi kit.

According to the company, the kit uses 27-mer duplex RNAs, which are processed by Dicer in 21-mer siRNAs. The kit includes thee target-specific Dicer-substrate siRNA duplexes, a fluorescent-labeled transfection control duplex, a positive control duplex, a universal negative control duplex, and RNase-free duplex buffer.

Additional information about the Trifecta kit can be found at http://www.idtdna.com/Catalog/Trifecta/Page1.aspx.


Qiagen has just introduced its new human druggable genome siRNA set version 2.0, the company said this week.

The company noted that it delivered the new set to the Scripps Research Institute.


Sigma-Aldrich has recently expanded its Mission TRC shRNA library to include lentiviral transduction particles.

According to the company, the expansion was made through an exclusive agreement with The RNAi Consortium.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.